"Purdue Pharma Lawsuit 2017: Latest Updates & Impact on Opioid Crisis"

Purdue Pharma's 2017 Lawsuit: A Deep Dive into the Opioid Crisis

The year 2017 marked a significant turning point in the ongoing opioid crisis, with Purdue Pharma, the manufacturer of OxyContin, facing a barrage of lawsuits. This article delves into the details of these lawsuits, their impact, and the broader context of the opioid epidemic.

Understanding Purdue Pharma and OxyContin

Purdue Pharma, a privately-held pharmaceutical company, is owned by the Sackler family. It introduced OxyContin, a powerful, long-acting opioid painkiller, in 1996. Despite its high potential for abuse, Purdue Pharma aggressively marketed OxyContin, leading to a surge in prescriptions and, subsequently, addiction and overdose deaths.

The 2017 Lawsuits: A Tipping Point

In 2017, several states and counties filed lawsuits against Purdue Pharma, alleging that the company had misled doctors and patients about the risks of OxyContin. These lawsuits were part of a growing wave of legal actions against pharmaceutical companies, distributors, and retailers accused of fueling the opioid crisis.

Purdue Pharma settlement: OxyContin maker reaches tentative deal to ...

  • State of Ohio vs. Purdue Pharma: Filed in May 2017, this lawsuit accused Purdue Pharma of deceptively marketing OxyContin and contributing to the state's opioid crisis.
  • City of Chicago vs. Purdue Pharma: Filed in June 2017, this lawsuit alleged that Purdue Pharma's deceptive marketing practices led to an increase in opioid addiction and overdose deaths in Chicago.

Other Notable 2017 Lawsuits

Other notable lawsuits filed in 2017 included those by the states of Missouri, New Mexico, and the counties of Cuyahoga (Ohio) and Lackawanna (Pennsylvania). These lawsuits echoed similar allegations of deceptive marketing and contributing to the opioid crisis.

The Impact of the 2017 Lawsuits

The 2017 lawsuits against Purdue Pharma brought renewed attention to the opioid crisis and the role of pharmaceutical companies in it. They also set a precedent for future legal actions, with many of the allegations and strategies employed in these lawsuits being replicated in subsequent litigation.

Year Number of Opioid-Related Lawsuits Filed
2017 15
2018 44
2019 111

As the table above shows, the number of opioid-related lawsuits filed each year increased significantly after 2017, indicating the growing recognition of the crisis and the need for accountability.

Judge orders release of redacted sections in Purdue Pharma lawsuit ...

Purdue Pharma's Response and Settlement

In response to the lawsuits, Purdue Pharma maintained that it had acted responsibly and that its marketing practices were appropriate. However, in 2020, the company filed for bankruptcy as part of a settlement agreement with the U.S. Department of Justice and several states. The settlement included a $3.54 billion criminal penalty and required Purdue Pharma to cease operations and be sold.

The Sackler family also reached a settlement with the Justice Department in 2021, agreeing to pay $225 million and relinquish control of Purdue Pharma. However, many of the lawsuits against Purdue Pharma and the Sackler family continue, with plaintiffs alleging that the settlements do not go far enough in holding the company and the family accountable for their role in the opioid crisis.

Purdue Pharma settlement: OxyContin maker reaches tentative deal to ...

Purdue Pharma settlement: OxyContin maker reaches tentative deal to ...

Judge orders release of redacted sections in Purdue Pharma lawsuit ...

Judge orders release of redacted sections in Purdue Pharma lawsuit ...

The Supreme Court Blocks Purdue Pharma's $6 Billion Opioid Settlement

The Supreme Court Blocks Purdue Pharma's $6 Billion Opioid Settlement

Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits ...

Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits ...

Purdue Pharma Pleads Guilty to Criminal Charges for Opioid Sales - The ...

Purdue Pharma Pleads Guilty to Criminal Charges for Opioid Sales - The ...

Purdue Pharma Pleads Guilty to Role in Opioid Crisis - The New York Times

Purdue Pharma Pleads Guilty to Role in Opioid Crisis - The New York Times

Purdue Pharma and Sacklers Reach $270 Million Settlement in Opioid ...

Purdue Pharma and Sacklers Reach $270 Million Settlement in Opioid ...

Purdue Pharma Files for Bankruptcy in Opioid Lawsuit Settlement

Purdue Pharma Files for Bankruptcy in Opioid Lawsuit Settlement

Purdue Pharma to plead guilty in $8bn opioid settlement - BBC News

Purdue Pharma to plead guilty in $8bn opioid settlement - BBC News

Supreme Court to hear Purdue Pharma case that could shake up opioid ...

Supreme Court to hear Purdue Pharma case that could shake up opioid ...

What the Supreme Court’s Decision to Hear the Purdue Pharma Case Means ...

What the Supreme Court’s Decision to Hear the Purdue Pharma Case Means ...

Supreme Court Weighs Purdue Pharma’s $6 Billion Opioid Settlement - WSJ

Supreme Court Weighs Purdue Pharma’s $6 Billion Opioid Settlement - WSJ

Supreme Court ruling against Purdue Pharma makes it harder to shield ...

Supreme Court ruling against Purdue Pharma makes it harder to shield ...

Purdue Pharma Faces $2.15 Trillion Opioid Epidemic Lawsuit From 49 States

Purdue Pharma Faces $2.15 Trillion Opioid Epidemic Lawsuit From 49 States

Purdue Pharma bankruptcy judge pauses insurance lawsuit in favor of ...

Purdue Pharma bankruptcy judge pauses insurance lawsuit in favor of ...

Ruling clears way for Purdue Pharma to settle opioid claims, protect ...

Ruling clears way for Purdue Pharma to settle opioid claims, protect ...

Purdue Pharma lawsuit lands Trumbull County $2.5 million

Purdue Pharma lawsuit lands Trumbull County $2.5 million

Purdue Pharma faces more lawsuits

Purdue Pharma faces more lawsuits

Purdue Pharma asks judge to dismiss NH's lawsuit against it

Purdue Pharma asks judge to dismiss NH's lawsuit against it

Purdue Pharma Victim Settlement Payments Over Opioid Use Could Reach ...

Purdue Pharma Victim Settlement Payments Over Opioid Use Could Reach ...